lanreotide
Pronunciation: lan-REE-oh-tide
Long-acting somatostatin analog medication used to treat neuroendocrine tumors and acromegaly.
Full Definition
Lanreotide is a synthetic long-acting somatostatin analog administered as a depot injection for the treatment of neuroendocrine tumors and acromegaly. It works by binding to somatostatin receptors, particularly subtypes 2 and 5, to inhibit hormone secretion and tumor growth. In neuroendocrine tumors, lanreotide helps control symptoms from hormone hypersecretion and may provide antiproliferative effects. The medication is typically given as monthly deep subcutaneous or intramuscular injections. Common side effects include gastrointestinal symptoms, injection site reactions, and potential gallstone formation. Lanreotide represents an important therapeutic option in the management of well-differentiated neuroendocrine tumors.
Usage
Usage note: Do not confuse with octreotide; specify dose and formulation when prescribing.
In Context
- "The patient will begin lanreotide 120 mg depot injections monthly for neuroendocrine tumor control." — Treatment plan
- "Lanreotide therapy resulted in significant reduction of carcinoid syndrome symptoms." — Clinical progress note